Private company

IsoPlexis Corp

American laboratory analytical instruments company, incorporated in Delaware.

Last updated Oct 18, 2026.

Overview

  • IndustryLaboratory Analytical Instruments
  • HeadquartersDE
  • Incorporated inDE2
  • Business address35 Ne Industrial Road, Branford, Ct 064052
  • Filer category, Emerging growth company2

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-5.5%Gross margin3
-604.0%Operating margin3
-632.4%Net margin3
-2.9%Revenue growth, 20223
-256.9%Return on equity3
1.12×Debt to equity3
-$104.0MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Research and development100¢$23.5M

Out of $16.8M in revenue.3 The company lost money this year.

Financial statements

Revenue43$16.8M in 2022+61% since 2020
0$5.0M$10.0M$15.0M$20.0M2020: $10.4M$10.4M20202021: $17.3M$17.3M2021+66%2022: $16.8M$16.8M2022−3%
Gross profit43-$925.0K in 2022
-$2.5M0$2.5M$5.0M$7.5M$10.0M2020: $5.4M$5.4M20202021: $8.8M$8.8M2021+62%2022: -$925.0K-$925.0K2022
Operating income43-$101.2M in 2022+271% since 2020
-$150.0M-$100.0M-$50.0M02020: -$27.3M-$27.3M20202021: -$76.3M-$76.3M2021+180%2022: -$101.2M-$101.2M2022+33%
Net income3-$106.0M in 2022+30% since 2020
-$150.0M-$100.0M-$50.0M02020: -$81.6M-$81.6M20202021: -$81.6M-$81.6M2021−0%2022: -$106.0M-$106.0M2022+30%
Fiscal year2019202020212022
Revenue$10.4M4$17.3M3$16.8M3
Gross profit$5.4M4$8.8M3-$925.0K3
Research and development$11.2M4$21.0M3$23.5M3
Operating income-$27.3M4-$76.3M3-$101.2M3
Net income-$81.6M3-$81.6M3-$106.0M3
Earnings per share-$14.064-$8.993-$2.703
Earnings per share (diluted)-$14.064-$8.993-$2.703

Compare IsoPlexis Corp with another company

Leadership

Who has led IsoPlexis Corp, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Sean Mackay2021–2023

Chief financial officer

  1. John Strahley2021–2023
2025
Board members and other officers (11)

Timeline

  1. Oct 7, 2021New chief executive Sean Mackay becomes CEO7

Filings

138 filings to the SEC since October 2021: 2 annual reports, 4 quarterly reports, 20 major events, 60 insider forms, 12 large holders, 40 other. The latest 20:

  1. Jun 15, 2023SC 13D/A EDGAR
  2. Mar 31, 202315-12G EDGAR
  3. Mar 22, 20238-K EDGAR
  4. Mar 21, 2023S-8 POS EDGAR
  5. Mar 21, 2023S-8 POS EDGAR
  6. Mar 21, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  7. Mar 21, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  8. Mar 21, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  9. Mar 21, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  10. Mar 21, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  11. Mar 21, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  12. Mar 21, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  13. Mar 21, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  14. Mar 21, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  15. Mar 21, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  16. Mar 16, 2023425 EDGAR
  17. Mar 16, 2023425 EDGAR
  18. Mar 16, 20238-K EDGAR
  19. Mar 14, 20234 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  20. Mar 9, 2023DEFA14A EDGAR

The 138 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 12 such filings since October 2021, the latest 10:

  1. Jun 15, 2023SC 13D/A
  2. Feb 14, 2023SC 13G/A
  3. Feb 14, 2023SC 13G/A
  4. Feb 14, 2023SC 13G/A
  5. Feb 1, 2023SC 13G/A
  6. Dec 22, 2022SC 13D/A
  7. Feb 14, 2022SC 13G/A
  8. Jan 26, 2022SC 13G
  9. Jan 25, 2022SC 13G
  10. Dec 23, 2021SC 13G

From Forms 4 and Schedules 13D and 13G filed with the SEC.